Determinants of responsiveness to 5-fluorouridine in transplantable murine leukemias.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001673:Biodegradation, Environmental; D001692:Biological Transport; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004261:DNA Replication / Q000187:drug effects; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003857:Deoxyuridine / Q000378:metabolism; D004351:Drug Resistance; D005467:Floxuridine / Q000627:therapeutic use; D005461:Fluorine / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D005472:Fluorouracil / Q000378:metabolism / Q000494:pharmacology; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology; D051379:Mice; D009368:Neoplasm Transplantation; D010430:Pentosyltransferases / Q000032:analysis; D010770:Phosphotransferases / Q000032:analysis; D014529:Uridine / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D005467:Floxuridine; D005461:Fluorine; D010430:Pentosyltransferases; D010770:Phosphotransferases; D005472:Fluorouracil; D003857:Deoxyuridine; D014529:Uridine